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Abstract:  Hypotension is frequently reported during hemodialysis. This study aimed to 
examine  the  effect  of  the  intermittent  pneumatic  circulator  on  blood  pressure  during 
hemodialysis.  Sixteen  subjects  with  chronic  hemodialysis  were  recruited.  Each  subject 
randomly received two test conditions on separate days, hemodialysis with and without  
the  circulator.  The  circulator  was  applied  to  the  subject  on  lower  extremities  
during 0.5–1 hr, 1.5–2 hr, 2.5–3 hr, and 3.5–4 hr of hemodialysis. Systolic and diastolic 
blood pressures (SBP and DBP) and heart rate (HR) were analyzed at pre-dialysis, 1 hr, 2 hr, 
and 3
 hr of hemodialysis. Stroke volume (SV) and cardiac output (CO) were evaluated 
between 2.5 and 3.0 hr of hemodialysis. Blood chemicals (sodium, calcium, potassium, and 
phosphorous) and Kt/V before and after each hemodialysis session were analyzed. The 
number  of  episodes  of  hypotension  was  also  recorded.  The  circulator  intervention 
significantly improved SBP and DBP across all time points (P = 0.002 for SBP; P = 0.002 
for DBP). The frequency of hypotension was significantly decreased (P = 0.028). SV and 
CO were significantly improved with the circulator intervention (P = 0.017 for SV; P = 0.026 
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for CO) and no statistical significances were found on blood chemicals or Kt/V analyses. 
The results suggested that the circulator intervention helps stabilize blood pressure and 
appears  to  be  a  practical  treatment.  Future  studies  are  suggested  to  develop  new  
circulator  innovations  with  sensor  feedback  systems  to  enhance  safety  and  maximize  
treatment efficiency. 
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1. Introduction  
Hypotension during hemodialysis is one of the more frequently reported hemodynamic instabilities. 
The prevalence of a symptomatic reduction in blood pressure during or immediately after hemodialysis 
ranges from 15 to 50 percent of dialysis sessions [1,2]. In addition to drops in blood pressure, other 
manifestations may include vomiting, muscle cramps, and other vagal symptoms, such as yawning and 
drowsiness.  Hemodialysis-induced  hypotension  may  prevent  uremic  patients  from  a  safe  and 
comfortable treatment, reduce treatment efficacy, further decrease residual renal function and increase 
morbidity  related  with  dialysis  procedures  [3].  It  has  been  reported  that  hemodialysis-related 
hypotension  is  an  independent  determinant  associated  with  myocardial  stunning  [4].  Repetitive 
myocardial ischemia can be cumulative and may lead to left ventricular dysfunction [5-7], which may 
further aggravate hypotension during hemodialysis [8,9]. Long-term effects of severe and repeated 
hypotension  may  be  associated  with  cardiovascular  diseases,  such  as  heart  failure,  and  increase 
mortality in individuals with hemodialysis [4,10].  
The mechanism of hemodialysis-induced hypotension is not fully understood. The determinants of 
arterial blood pressure are cardiac output and total peripheral vascular resistance. Research has shown 
that factors affecting cardiac output and/or peripheral resistance, such as diminished cardiac reserve [11], 
increased synthesis of endogenous vasodilators [12], and failure to increase plasma vasopressin levels [13] 
contribute to dialysis-related hypotension. Other contributory factors may be related to characteristics 
of patients, such as age, and dialysis methodology, including rapid fluid removal in an attempt to attain 
“dry  weight”  [14],  and  use  of  acetate  rather  than  bicarbonate  as  a  dialysate  buffer  [9,15],  etc.  
Among those factors mentioned above, hypovolemia induced by ultrafiltration has been considered the 
major cause of an acute decrease of blood pressure during hemodialysis treatment [16,17]. 
The intermittent pneumatic circulator is an electronic mechanical pump commonly used in physical 
therapy with the main purpose of controlling or reducing edema, prevention of thrombophlebitis, and 
improving peripheral  circulation  [17,18]. The circulator intermittently pumps air into an inflatable 
sleeve or boot where an upper or lower extremity has been inserted. During pumping, the air pressure 
surrounding the extremity increases and thus the fluids in the interstitial spaces of the extremity are 
facilitated to return to the venous and lymphatic vessels and then to the heart. Therefore, theoretically, 
the circulator should be able to improve drops in blood pressure during hemodialysis by increasing 
preload to the heart. However, no research has been done to test this conjecture. This study aimed to 
examine the effect of the circulator on blood pressure during hemodialysis. We hypothesized that the 
circulator would improve drops in blood pressure. Sensors 2010, 10                                       
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2. Methods 
2.1. Participants and Dialysis Prescription 
Sixteen subjects (six males and 10 females) with chronic hemodialysis and with any episode of 
hypotension during hemodialysis in the past three months were recruited. The hemodialysis-related 
hypotension was defined as the level of blood pressure low enough to require nursing or medical 
intervention or drops in systolic blood pressure greater than 30 mmHg [19]. Their age, height, weight, 
and hemoglobin level were 48.8 ±  9.4 yrs, 158.5 ±  8 cm, 60.7 ±  10.7 kg, and 10.59 ±  1.97 g/dL, 
respectively. The patients underwent hemodialysis three times weekly, 3.5–4.0 hrs each time. The time 
of hemodialysis was 8.71 ±  4.06 yrs. The underlying causes of end-stage renal disease were diabetes, 
chronic glomerulonephritis, and hypertension. Two subjects were taking antihypertensive medications 
and the dose of medications was kept the same during this study period. On the day of hemodialysis, 
these two subjects did not take the medications. 
The  dialysis  was  performed  using  either  a  polysulphone  or  a  polymethylmethacrylate (PMMA) 
dialyser. The surface membrane area ranged from 1.6 m
2 to 2.2 m
2. The ultrafiltration (% body weight 
reduction) during dialysis sessions was adjusted according to the presumed dry weight (assessed as the 
post-dialysis patient’s weight when normotensive and free of edema). Dry weight was established by 
the attending physician. Dry weight and ultrafiltration were kept constant as possible for a specific 
subject throughout this study.  
The  subject  was  afebrile  (pre-dialysis  temperature  36.3–36.9  ° C)  and  the  temperature  of  the 
dialysate was kept constant at 37 ° C. The blood flow and dialysate flow rates were 250–300 mL/min 
and 500 mL/min, respectively. The dialysate chloride, bicarbonate, calcium, sodium, potassium, and 
glucose concentrations were 106.5–107.5 mEq/L, 39 mEq/L, 2.5–3.5 mEq/L, 138–141 mEq/L, 2.0 mEq/L, 
and 200 mg/dL, respectively. 
2.2. Experimental Procedure 
Written informed consent was obtained from the subject before enrollment in this study. Study 
protocols were conducted in accordance with the ethical guidelines of Kaohsiung Medical University. 
Each  subject  randomly  received  two  test  sessions  exactly  one  week  apart,  hemodialysis  with  and 
without the  circulator. For each test  session,  blood  pressure  (BP)  and heart rate (HR) were taken  
every 30 minutes with mercury sphygmomanometer and heart rate monitor (CheckMyHeart; DailyCare, 
Taipei, Taiwan) and the data at pre-dialysis, and 1 hr, 2 hr, and 3
 hr of hemodialysis were analyzed. 
Stroke volume (SV) and cardiac output (CO) were evaluated by Doppler echocardiography (Philips 
SONOS 5500; Philips, Seattle, WA, USA) in supine position between 2.5 and 3.0 hr of hemodialysis. 
SV was calculated by the following equation: SV = LVOT
2 ×  0.785 ×  VTI, where LVOT and VTI were 
left ventricle outflow tract and velocity-time integral, respectively. Blood was sampled before and after 
hemodialysis session and analyzed with a model 200FR automatic analyzer (Toshiba 200; Toshiba, 
Tokyo,  Japan)  for  sodium,  potassium,  calcium,  phosphorous,  and  blood  urea  (expressed  as  BUN) 
concentrations.  The  number  of  episodes  of  hypotension  during  hemodialysis  that  required  clinical 
intervention was also recorded. Delivered dose of dialysis (Kt/V, where K, t, and V are the clearance Sensors 2010, 10                                       
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(m
3/s), time (s), and the distribution volume of urea (m
3), respectively) was calculated according to 
National Kidney Foundation Disease Outcomes Quality Initiative (NKF-DOQI) recommendation. 
For the test session with the circulator intervention, the circulator (Power Q1000; Wonjin Mulsan 
Co.,  Ltd.,  Incheon,  Korea)  was  applied  to  the  subject  on  both  lower  extremities  (Figure  1)  for  
half an hour at 0.5 hr, 1.5 hr, 2.5 hr, and 3.5 hr of hemodialysis, with a total intervention time of two 
hours. The leg cuffs of the circulator were gradually inflated from distal to proximal (Figure 1). The 
pressure of pumping was determined by the comfort level of the subject, but was less than the subject’s 
diastolic blood pressure at pre-dialysis. 
Figure 1. (a) The circulator and its accessories; (b) The application of the circulator. 
 
(a) 
 
(b) 
2.3. Data Analysis 
Dependent variables include systolic blood pressure (SBP), diastolic blood pressure (DBP), HR, SV, 
CO, Kt/V, blood chemicals (sodium, calcium, potassium, and phosphorous), the number of episodes of 
hypotension, and ultrafiltration volume. Descriptive statistics was used to analyze mean and standard 
deviation  for  each  variable.  SBP,  DBP,  and  HR  were  expressed  as  a  percentage  of  the  baseline  
(pre-dialysis) SBP, DBP, and HR, respectively. The two-way repeated measures ANOVA was used to 
analyze the differences on SBP, DBP, and HR between hemodialysis with and without the circulator 
intervention.  Tukey-Kramer  test  was  employed  for  post-hoc  analysis  when  appropriate.  The  
paired-t test was used to analyze the differences on SV, CO, Kt/V, blood chemicals, the frequency of 
hypotension, and ultrafiltration volume. A significant level was set at 0.05. Sensors 2010, 10                                       
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3. Results 
The  mean  and  standard  deviation  of  SBP,  DBP  and  HR  at  different  time points  are shown in  
Table 1. As shown in Figure 2(a), regardless of whether dialysis was with or without circulator, SBP 
decreased  at  different  time  points.  The  ANONA  results  showed  significant  time  effects  on  SBP  
(Table  2).  The  post-hoc  test  revealed  that  compared  to  baseline,  SBP  at  1  hr  (P  =  0.010),  2  hr  
(P  <  0.001),  and  3  hr  (P  <  0.001)  of  hemodialysis  were  significantly  decreased.  As  shown  in  
Figure 2(b), for dialysis without circulator, DBP decreased across different time points and the extent 
of the decreased DBP appeared to be aggravated with the increase of time. For dialysis with circulator, 
DBP slightly increased at 1 hr, but decreased at 3 hr time point. The ANOVA results revealed that 
significant time effects on the DBP (Table 2). However, the post-hoc analysis showed that only the 
DBP at 3 hr (P < 0.001) significantly decreased, compared to the baseline. These results indicated 
hypotension occurred in our subjects during hemodialysis. 
Table 1. Mean and standard deviation of SBP, DBP, and HR at different time points. 
Without circulator 
  Baseline  1
 hr of dialysis  2 hr of dialysis  3 hr of dialysis 
SBP (mmHg)  151.8 ±  29.2  138.1 ±  30.9  116.3 ±  21.6  109.9 ±  21.2 
DBP (mmHg)  78.6 ±  12.2  75.3 ±  13.5  71.2 ±  16.0  65.3 ±  13.0 
HR (bpm)  86.3 ±  11.0  85.3 ±  11.2  89.8 ±  15.6  92.0 ±  15.3 
With circulator 
  Baseline  1
 hr of dialysis  2 hr of dialysis  3 hr of dialysis 
SBP (mmHg)  146.5 ±  28.0  137.4 ±  20.0  126.6 ±  19.2  114.9 ±  16.7 
DBP (mmHg)  79.1 ±  12.3  79.6 ±  10.3  78.4 ±  8.7  70.4 ±  8.8 
HR (bpm)  84.5 ±  10.4  83.1 ±  13.1  88.6 ±  15.2  88.1 ±  17.6 
Figure 2. Mean and standard errors of SBP, DBP, and HR at different time points: (a) SBP; 
(b) DBP; (c) HR. (*A significant level was set at 0.05). 
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Figure 2. Cont. 
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Table 2. The two-way (with/without circulator by time points) ANOVA summary. 
  SBP  DBP  HR 
F  P  F  P  F  P 
With/without circulator  10.15  0.002
*  9.73  0.002
*  0.09  0.769 
Time point  41.66  <0.001
*  9.87  <0.001
*  4.78  0.004
* 
Interaction  1.72  0.168  1.34  0.266  0.10  0.960 
*A significant level at 0.05. 
 
As for the intervention effects of the circulator, the ANOVA revealed that dialysis with circulator 
significantly attenuated the drops in SBP and DBP across different time points (Table 2). The number 
of episodes of hypotension for hemodialysis with and without the circulator intervention was 1.56 ±  0.96 
and 0.94 ±  0.77 respectively, and the paired-t revealed significantly decreased episodes for dialysis Sensors 2010, 10                                       
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with  the  circulator  (P  =  0.028).  These  results  supported  our  hypothesis  that  the  circulator  would 
improve blood pressure during hemodialysis. 
As shown in Figure 2(c), regardless of whether dialysis was with or without circulator, the HR 
decreased at 1 hr but increased afterwards. The ANOVA results showed significant time effects on HR. 
However, the post-hoc test revealed that compared to the HR at baseline, no significant differences 
were found at all time points. The ANOVA results showed no effect of circulator intervention on HR. 
Two subjects refused the Doppler echocardiography examination. The mean and standard deviation 
(N = 14) for SV with and without circulator were 58.80 ±  18.62 L/min and 45.16 ±  17.71 mL/min, 
respectively. HR with and without circulator were 88.4 ±  18.9 bpm and 89.7 ±  16.8 bpm, respectively. 
CO with and without circulator was 5.06 ±  1.51 L/min and 3.98 ±  1.50 L/min, respectively. The paired-
t test showed that compared to dialysis without circulator, both the SV (P = 0.017) and the CO (P = 
0.026)  were  significantly  increased  with  the  circulator  intervention,  while  no  difference  in  HR  
(P = 0.551).  
The Kt/V, indicating the efficiency of hemodialysis, was 1.38 ±  0.37 for dialysis with circulator  
and 1.36 ±  0.34 for dialysis without circulator. No significant difference for Kt/V between dialysis with 
and without circulator was found (P = 0.245). The mean and standard deviation for sodium, calcium, 
potassium, and phosphorous are presented in Table 3. No significant differences were found between 
dialysis with and without circulator (P = 0.894 for sodium, P = 0.370 for calcium, P = 0.683 for 
potassium,  and  P  =  0.744  for  phosphorous).  The  mean  values  for  ultrafiltration volume with  and 
without circulator were 3.51 ±  0.97 kg and 3.39 ±  1.18 kg, respectively. The paired-t test revealed that 
no significant differences (P = 0.39) on fluid removal were found between two test sessions. 
Table 3. Mean and standard deviation of sodium, calcium, potassium, and phosphorous. 
  Without circulator  
Sodium (meq/L)  Calcium(mg/dl)  Potassium(meq/L)  Phosphorous(meq/L) 
Before dialysis  135.94 ±  3.99  9.56 ±  1.19  4.49 ±  0.90  5.14 ±  1.72 
After dialysis  138.27 ±  3.08  10.55 ±  0.73  3.55 ±  1.00  2.31 ±  1.15 
  With circulator 
Sodium (meq/L)  Calcium(mg/dl)  Potassium(meq/L)  Phosphorous(meq/L) 
Before dialysis  135.94 ±  3.36  9.79 ± 0.22  4.44 ±  1.06  5.18 ±  1.96 
After dialysis  138.19 ±  3.73  10.39 ±  1.13  3.69 ±  0.94  2.55 ±  1.25 
4. Discussion 
Hypotension is one of the most common complications seen during hemodialysis. Repeated severe 
symptomatic  hypotension  might  result  in  brain  and  cardiac  tissue  damage,  and  correlates  with  
long-term cardiovascular problems [4,20]. Previous studies reported up to 50% drop in SBP [21,22]. In 
our  study,  the  amount  of  decreased  SBP  during  dialysis  without  circulator  intervention  ranged  
from 9% (1 hr) up to 27% (3 hr) , which appears to be at the lower end of the range reported. We 
recruited  hypotension-prone  subjects,  while  some  research  had  more  severe  inclusion  criteria  for 
subject selection, such as at least a 25% drop in SBP. Recruitment criteria/characteristics for subjects 
might  contribute  to  the  wide  range  of  hemodialysis  hypotension  seen  in  the  literature.  Gender 
differences on hemodialysis-related hypotension are controversial [2]. We further analyzed our data Sensors 2010, 10                                       
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and found no significant gender differences on reductions in SBP across all time points, though female 
and male subjects had up to 28% and 23% drops in SBP respectively.  
The  intermittent  pneumatic  pressure  pump  or  circulator  is  usually  used  in  physical  therapy  to 
facilitate peripheral circulation. It is speculated to be able to improve drops in blood pressure during 
hemodialysis by increasing venous return to the heart, according to its theoretical beneficial effects. 
However, to our knowledge, this is the first study to substantiate this conjecture. In our study, though 
the SBP during hemodialysis with circulator was still dropped but the extent of the decreased SBP was 
significantly improved from 9% to 5% at 1 hr and 27% to 19% at 3 hr. In addition, the number of 
episodes of hypotension that required clinical intervention was significantly reduced with the circulator 
intervention (P = 0.028). It is noteworthy that the circulator intervention may be also effective for the 
hemodialysis patient with chronic hypotension defined as SBP less than 100 mmHg in the interdialytic 
period [23,24]. One of our subjects had chronic hypotension and appeared to respond well to the 
intervention.  Without  the  circulator  intervention,  SBP  during  hemodialysis  was  gradually  dropped 
from 3% at 1 hr to 15% at 3 hr, while SBP under the circulator intervention condition did not drop at 
the first two hours and only showed a drop of 10% at 3 hr.  
Adequate  blood  volume  is  important  to  maintain  a  stable  blood  pressure.  Hypovolemia  is 
considered  a  main  factor  contributing  to  dialysis-related  hypotension  [17].  Poldermans  et  al. 
investigated the presence of myocardial ischemia and myocardial contractile reserve during infusions 
of  the  β-adrenergic  receptor  agonist  dobutamine  in  hypotension-prone  and  hypotension-resistant 
hemodialysis patients and proposed that hemodialysis-induced hypovolemia caused a fall in cardiac 
filling pressure and thus decrease in CO. Consequently, sympathetic nervous system was activated to 
adequately increase CO. If not, hypotension happened. This proposed mechanism has been evidenced 
by studies finding that drops in blood pressure were often paralleled by reductions in blood volume 
expressed by a percentage of the starting blood pressure [25,26]. In our study, with circulator, an 
increase of 27.1% in CO was found and this might significantly contribute to more stable SBP seen 
during dialysis with circulator. However, due to equipment accessibility and subject compliance, we 
did not measure CO for multiple time points. Therefore, we won’t be able to examine the relationship 
between CO and decreased blood pressure with time.  
Normal  compensatory  cardiac  strategies  to  prevent  hypovolemia  are  to  increase  in  HR  and 
contractility. However, an increase in HR, caused by beta-adrenergic activation, is of relatively minor 
importance in maintaining blood pressure [27]. Thus, diminished ability to increase contractility will 
cause  increased  sensitivity  to  hypovolemia,  which  is  especially  true  for  dialysis  patients  with  left 
ventricular  diastolic  dysfunction.  In  case  of  extreme  intracardial  hypovolemia,  in  order to  prevent 
myocardial damage, a cardio-inhibitory reflex might be induced and results in bradycardia and further 
aggravate hypotension [28]. Obviously, this is not the case in our study. Our subjects demonstrated that 
compared  to  baseline,  small  reductions  in  HR  at  the  first  hour  of  hemodialysis  session  but  HR 
increased later on (Figure 2(c)). The initial drops in HR might be due to the decrease in blood volume 
caused by ultrafiltration and the increased HR afterwards might result from an activation of baroreflex 
as a compensatory strategy for hypovolemia. However, even though there were fluctuations in HR 
responses, no significant differences across time points were found, suggesting HR may be a minor 
contributory factor to prevent hemodialysis hypotension, as mentioned above. This is further evidenced Sensors 2010, 10                                       
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by our data from echocardiograpy, which showed that during hemodialysis with circulator, CO was 
predominantly improved as a result of significantly increased SV, instead of HR. 
Blood pressure is determined by CO and total peripheral resistance. In our study, we were unable to 
utilize a doppler echocardiography to continuously monitor CO during hemodialysis. Therefore, we did 
not know if CO changes paralleled with drops in blood pressure throughout dialysis process. Previous 
studies suggested impaired baroreflex sensitivity and arteriovenous tone adjustment to hypovolemia 
might be associated with hemodialysis-induced hypotension [29,30]. It is unknown if those factors 
contributed to drops in blood pressure of our subjects, due to lack of measurements on baroreflex 
sensitivity and total peripheral resistance in this study. 
The Kt/V, and other blood chemical analyses (sodium, potassium, calcium, phosphorous) were not 
significant, indicating the circulator intervention had no influence on clearance of blood chemicals. 
The Kt/V is a multiple of the volume of plasma cleared of urea divided by the distribution volume of 
urea and has been considered an indicator of hemodialysis efficiency. An increase in CO possibly 
facilitates the clearance of urea during dialysis. However, in  our study, the circulator intervention 
appeared not to enhance the efficiency of hemodialysis, though a significant increase in CO was found. 
Nevertheless, one should note that our subjects only received the circulator intervention for a total of 
two hours during a 3.5 to 4.0 hour dialysis session. The influence of the circulator intervention for a 
longer period of time on the efficiency of hemodialysis deserves more investigations. In addition, a 
small  sample  size  of  16  may  limit  the  power  for  the  circulator  intervention  to  show  significant 
differences on Kt/V. A post-hoc power analysis using a two-tail significant test revealed that the effect 
size of the circulator intervention on Kt/V was only 0.33. A larger sample size is suggested for the 
future study to achieve statistical power. 
Kyperkalemia rebound after hemodialysis, i.e., the increment of plasma potassium detectable within 
the initial few hours after dialysis, may potentially cause fatal cardiac arrhythmia, and enhanced muscle 
weakness  and  fatigue  [31,32].  It  is  associated  with  redistribution  of  potassium  between  
intra-/extracellular  compartments  post  hemodialysis  [33].  Kong  et  al.  found  exercise  during 
hemodialysis  could  improve  hyperkalemia  rebound.  The  underlying  mechanism  governing  this 
improvement was suggested to be related to the increase of plasma concentration of potassium as a 
result of efflux from the contracting muscles and thus, the potassium removal during hemodialysis was 
enhanced  [34].  In  our  study,  the  circulator  intervention  mimic  massage  movements  on  lower 
extremities of the subject [35], which may potentially aid in potassium removal during hemodialysis.  
Several types of pneumatic circulators are available on market. The circulator used in this study 
provided  a  gradient  design,  which  was  designed  to  incorporate  the  massage  effect  of  a  distal  to 
proximal pressure with a gradual decrease in the pressure gradient. Some other types of intermittent 
circulator can control timing of pumping during appropriate heart cycle, such as a more advanced 
innovation, the end-diastolic pneumatic boot. Dillon et al. found the increases in CO and SV were 
greater for pumping during end-diastolic phase than during systolic phase while afterload was much 
increased for pumping during systolic phase [36]. Timing of pumping appears to affect the preload and 
afterload of the heart and thus influences CO. Coupling between the cardiac cycle and pumping may 
enhance  the  venous  return  and  should  be  taken  into  account  when  developing  new  circulators. Sensors 2010, 10                                       
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Furthermore, clinical research is warrant to investigate whether these new circulators with sensors to 
control the timing of pumping provide better improvement on hemodialysis hypotension.  
Intermittent pneumatic circulator might expel arterial blood from the legs, potentially worsening 
peripheral ischemia and thus inducing muscle cramps and increasing discomfort, which is especially 
true in higher compression pressure settings. A pressure approximating the patient’s DBP has been 
suggested  to  be  used  in  most  treatment  protocols  [37].  Our  pressure  setting  complied  with  this 
principle. Though a couple of our subjects complained of muscle cramps, all of them had had prior 
history of muscle cramps before entry of this study. Namely, the circulator intervention did not induce 
higher incidence of muscle cramps during hemodialysis. In addition, no patients reported the increase 
of  discomfort  for  using  the  circulator.  It  appears  that  the  application  of  the  circulator  during 
hemodialysis  is  practical.  However,  as  high  compression  pressure  might  cause  tissue  ischemia,  a 
circulator will provide a safer and more efficient intervention if it has a sensor control feedback system 
which can monitor the subject’s DBP throughout the circulator intervention and automatically adjust 
the  pumping  pressure  to  the  appropriate  level.  This  type  of  the  circulator  would  be  particularly 
beneficial in long-term use for the subject whose DBP may fluctuate during the circulator intervention, 
such as individuals with hemodialysis or instable cardiac hemodynamics. 
Basically, the circulator intervention improves drops in blood pressure during hemodialysis through 
the mechanism of increasing venous return. Other interventions based on the similar principal may be 
also useful to prevent hemodialysis-related hypotension, such as abdominal compression. Abdominal 
compression has been shown to help overcome orthostatic hypotension [38-40], including post-dialytic 
orthostatic hypotension [38]. Therefore, it may also aid in improving hypotension during hemodialysis, 
though to our knowledge, evidence in this case has not been reported. 
In  summary,  even  though  hypotension  still  occurred  during  hemodialysis,  the  degree  of  the 
decreased  blood  pressure  was  significantly  improved  with  the  circulator  intervention by means  of 
increasing preload to the heart. Furthermore, the frequency of hypotension during hemodialysis was 
significantly decreased. The circulator intervention was evidenced to help stabilize blood pressure. In 
our study, the total treatment time of the circulator intervention was only about 50% of a hemodialysis 
session. In addition, the circulator used in this study was unable to pump in accordance with heart 
cycles, nor adjust compression pressure to cope with the subject’s DBP. These limitations of this study 
might  minimize  the  extent  of  improvement  seen  in  the  circulator  intervention.  Developing  more 
advanced circulators with sensor feedback systems is recommended and would enhance the application 
of the circulator intervention. 
5. Conclusions and Clinical Application 
Hypotension  during  hemodialysis  is  a  common  reported  complication.  Intermittent  pneumatic 
circulator can attenuate drops in blood pressures and appears to be a practical intervention. Future 
studies are suggested to develop new circulator innovations with sensor feedback systems to enhance 
safety and maximize treatment efficiency.  Sensors 2010, 10                                       
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